• Silymarin Workflows for Translational Research

  2026-09-11

  Build reproducible Silymarin experiments by controlling solvent, mixture composition, dosing, and orthogonal readouts. This workflow connects oxidative stress, hepatocellular carcinoma, metabolic, and antiviral models while highlighting the limits of interpreting a complex milk thistle extract as a single compound.

• Lenalidomide (CC-5013) in Myeloma Assays

  2026-09-11

  Build reproducible Lenalidomide workflows that separate direct cytotoxicity from immune remodeling, TNF-alpha suppression, and angiogenesis effects. A paired DOT1L–CC-5013 design can reveal how innate immune reprogramming strengthens multiple myeloma research readouts.

• DiR for Membrane Imaging and Nanomedicine Tracking

  2026-09-10

  DiR combines long-lasting membrane retention with near-infrared, low-background imaging for cell tracking, neuronal tracing, and tissue studies. This guide also shows how it can serve as an exploratory localization readout for trypsin-responsive nanomedicine workflows inspired by acute pancreatitis research.

• a-MSH, amide in Melanin Synthesis Research

  2026-09-10

  Use a-MSH, amide as a defined melanocortin challenge to build reproducible pigmentation, receptor-signaling, and inflammation assays. This workflow connects melanin measurements with viability, CREB/MITF readouts, and practical troubleshooting for stronger mechanistic conclusions.

• PP2A, Autophagy, and Candida Biofilm Drug Resistance

  2026-09-09

  The reference study identifies a PP2A–Atg13–Atg1 autophagy axis that contributes to Candida albicans biofilm formation and antifungal resistance. By combining PPH21 deletion, rapamycin-induced autophagy, cellular assays, and an oral infection mouse model, the work links fungal signaling biology with reduced treatment efficacy.

• Carbenoxolone disodium: Practical Research Guide

  2026-09-09

  Carbenoxolone disodium is an exploratory 11β-hydroxysteroid dehydrogenase inhibitor for studying glucocorticoid access, corticosterone metabolism, and gap junction communication in cell and tissue workflows. It should be paired with vehicle, viability, and pathway controls and should not be treated as a selective target-validation probe or an in vivo efficacy treatment.

• T7 RNA Polymerase: Mechanism and Applications

  2026-09-09

  T7 RNA Polymerase is a recombinant enzyme expressed in E. coli that selectively transcribes RNA from DNA templates carrying a T7 promoter. Its defined template compatibility supports in vitro transcription, RNA vaccine production, and antisense RNA and RNAi research, while the product documentation defines storage and research-use boundaries.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-08

  This study develops a patient-specific gastric cancer assembloid model by combining matched tumor organoids with separately expanded stromal cell subpopulations. The resulting system captures microenvironment-dependent gene expression and drug-response differences that are obscured in tumor-only cultures, supporting more informative studies of resistance and personalized treatment strategies.

• T7 RNA Polymerase for Cardiac RNA Assays

  2026-09-07

  Build reproducible RNA probes, standards, and translation templates for mechanistic studies of HEY2-linked cardiac metabolism. This workflow combines promoter-defined transcription, practical quality control, and troubleshooting for applications ranging from cardiac gene regulation to antisense RNA and RNAi research.

• Rosiglitazone Workflows for Beige Adipocyte Research

  2026-09-07

  Rosiglitazone, also known as Brl-49653, provides a controllable PPARγ stimulus for adipogenesis, insulin-response, and metabolic disease assays. This workflow pairs receptor-level pharmacology with the SEMA3E–β-catenin–thermogenesis framework to separate adipocyte differentiation from mitochondrial function.

• TGFBR1 Silencing in HFpEF: Study Insights

  2026-09-05

  A 2025 PLOS ONE study identifies TGFBR1 as a potential regulator of myocardial fibrosis, hypertrophy, and remodeling in a mouse model of HFpEF. Silencing TGFBR1 improved cardiac phenotypes while implicating Smad2/3, MAPK, and TAK1-associated PANoptosis pathways, providing a mechanistic basis for further validation rather than a completed therapeutic strategy.

• Lisinopril Dihydrate: From ACE Assay to Translation

  2026-09-04

  Lisinopril dihydrate is more than a routine ACE inhibitor control: it is a mechanistic probe for testing how renin–angiotensin signaling shapes cardiovascular and renal phenotypes. This thought-leadership guide connects ACE inhibition, peptidase selectivity, assay design, and translational strategy for hypertension, heart failure, myocardial infarction, and diabetic nephropathy research.

• EGTA for Calcium Signaling Assay Design

  2026-09-04

  EGTA, or egtazic acid, gives researchers a practical way to test whether extracellular calcium contributes to Piezo1-linked endothelial inflammation. This guide translates the Talin1–Piezo1–YAP findings into fresh-solution handling, assay workflows, controls, and troubleshooting decisions.

• BACE Inhibition, Amyloid-β, and Synaptic Transmission

  2026-09-03

  Satir et al. used optical electrophysiology and amyloid-β measurements to separate the effects of partial versus stronger BACE inhibition in primary cortical neurons. Their results indicate that reducing amyloid-β secretion by less than half did not impair synaptic transmission, whereas larger pharmacological effects were associated with synaptic suppression.

• Acridine Orange hydrochloride: Staining Guide

  2026-09-03

  Acridine Orange hydrochloride provides membrane-permeable, differential fluorescence for nucleic-acid staining, supporting DNA and RNA assessment in cell cycle analysis, apoptosis detection, and flow cytometry workflows. It is intended for nucleic-acid-focused assays rather than non-nucleic-acid targets, and prepared solutions should be used promptly instead of being stored long term.

8543 records 1/570 page Next 12345 下5页 Last page